Controversy Surrounds Palantir’s £330m NHS England Contract
The UK government’s partnership with US data analytics firm Palantir Technologies has sparked a significant debate over data privacy, government power, and the future of the National Health Service (NHS). At the center of the controversy is the Federated Data Platform (FDP), an AI-enabled system designed to connect disparate health information across the NHS to improve efficiency and patient care.
What is the Federated Data Platform (FDP)?
The FDP is a digital tool intended to integrate fragmented health data from across the NHS. Health Secretary Wes Streeting has stated that the platform is essential to bring the NHS “into the digital age.” Palantir, the company founded by Peter Thiel and Alex Karp, won the £330m contract in 2023 to deliver this system.
Key Concerns and Allegations
Despite the government’s goals, the deal has faced intense scrutiny from health bosses, human rights groups, and politicians. The primary concerns include:
- Potential for State Abuse: The health justice charity Medact has warned that the “highly interoperable nature” of Palantir’s software could enable “data-driven state abuses of power.” Specifically, there are fears that the platform could facilitate a UK version of US immigration raids, similar to how US Immigration and Customs Enforcement (ICE) uses Palantir software to track individuals using health data.
- Public Sector Presence: Critics are concerned about Palantir becoming deeply embedded in the UK public sector, noting that the company too holds contracts with the Ministry of Defence, several police forces, and the UK’s financial watchdog.
- Reputational Risk: Some health officials fear that Palantir’s global reputation may hinder the delivery of the contract.
The Government’s Response and Potential Exit
The controversy has reached a point where government ministers are reportedly exploring ways to exit the agreement. According to reports from April 2026, ministers have sought advice on triggering a “break clause” to terminate the £330m deal.
Chi Onwurah, the Labour MP and chair of the science, innovation and technology select committee, has stated that it was appropriate for the government to seek guidance on how to activate this break contract.
Palantir’s Defense
Palantir has strongly defended its role in the NHS. Louis Mosley, the company’s executive vice-chair in the UK, has urged the government to resist pressures from what he describes as “ideologically motivated campaigners.”
Mosley argues that abandoning the software would harm patient care and prevent the NHS from tackling its biggest challenges. He claims that the software is already delivering results and is forecast to provide £150m in benefits by the end of the decade, representing a £5 return for every pound spent.
Key Takeaways
- The Deal: Palantir is delivering the £330m Federated Data Platform (FDP) for NHS England.
- The Goal: To modernize the NHS by connecting fragmented health data using AI.
- The Risk: Critics fear “Big Brother-style” data sharing and potential government abuse of power.
- The Current Status: UK ministers are seeking advice on triggering a break clause to potentially end the contract.
Frequently Asked Questions
What is the FDP?
The Federated Data Platform (FDP) is an AI-enabled data platform designed to connect disparate health information across the NHS to improve operational efficiency.
Why is there a backlash against Palantir?
Opponents cite the company’s work with intelligence and military agencies and fear that its data-sharing capabilities could be misused by the state for surveillance or immigration enforcement.
Is the contract being cancelled?
Whereas the contract has not been officially cancelled, government ministers have sought advice on how to trigger a break clause to exit the deal.